Full Text View
Tabular View
No Study Results Posted
Related Studies
Age, Risk Factors for CVD and Cognitive Functioning
This study has been completed.
Study NCT00007397   Information provided by National Heart, Lung, and Blood Institute (NHLBI)
First Received: December 19, 2000   Last Updated: December 21, 2005   History of Changes

December 19, 2000
December 21, 2005
February 2000
 
 
 
Complete list of historical versions of study NCT00007397 on ClinicalTrials.gov Archive Site
 
 
 
Age, Risk Factors for CVD and Cognitive Functioning
 

To relate cardiovascular disease (CHD) risk factors to cognitive performance among middle-aged and elderly men and women over a 10 year longitudinal study period.

BACKGROUND:

The Framingham Heart Study is a major epidemiological investigation of prospective relationships between risk factors for the development of cardiovascular disease (CVD risk factors) and CVD risk factor outcomes. The Framingham Study and other large, prospective studies have resulted in an extensive literature on the impact of CVD risk factors (including age) and CVD outcomes. Comparatively, there have been many fewer studies of the impact of CVD risk factors on cognitive functioning, and possibly no studies of the effect of objectively measured, competing risk factors on cognitive functioning.

DESIGN NARRATIVE:

Dr. Elias and colleagues used cardiovascular risk factor data from the Framingham Heart Study (N= 2,123) in a prospective design allowing them to relate CVD risk factors (including age and gender) to two outcome measures: (1) level of cognitive performance and (2) change in cognitive performance over a 10 year longitudinal study period. The overall goals were to determine the best multivariate combination of biological and psychosocial risk factors for the prediction of lowered cognitive ability in middle-aged and elderly men and women, and to evaluate the relative impact of age, gender, and other biological and psychosocial risk factors on cognitive functioning.

 
Observational
Natural History, Longitudinal, Defined Population
  • Cardiovascular Diseases
  • Heart Diseases
  • Neurologic Manifestations
 
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Completed
 
January 2004
 

No eligibility criteria

Both
 
No
Contact information is only displayed when the study is recruiting subjects
 
 
NCT00007397
 
958
National Heart, Lung, and Blood Institute (NHLBI)
 
Investigator: Merrill Elias Boston University
National Heart, Lung, and Blood Institute (NHLBI)
December 2005

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP